Relapsed Malignant Mesothelioma
1 clinical trials · Condition
◉ Watch Relapsed Malignant Mesothelioma
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma (NCT02372227) | Verastem, Inc. | 2015-01-01 |
Track Relapsed Malignant Mesothelioma automatically
Every clearance here is in the API, with alerts when new ones post.